Flagship Pioneering Fund VII General Partner LLC - Insider Trading & Ownership

Location
55 Cambridge Parkway, 8 Th Floor, Cambridge, MA
Summary
The estimated value of insider holdings of Flagship Pioneering Fund VII General Partner LLC is at least $23M dollars as of May 24, 2024. Flagship Pioneering Fund VII General Partner LLC is the 10%+ Owner of Omega Therapeutics, Inc. and owns shares of Omega Therapeutics, Inc. (OMGAQ) stock worth about $10.6M. Flagship Pioneering Fund VII General Partner LLC is the 10%+ Owner of Seres Therapeutics, Inc. and owns shares of Seres Therapeutics, Inc. (MCRB) stock worth about $7.86M. Flagship Pioneering Fund VII General Partner LLC is the 10%+ Owner of Evelo Biosciences, Inc. and owns shares of Evelo Biosciences, Inc. stock worth about $4.52M.
Signature
Flagship Pioneering Fund VII General Partner LLC, By: Flagship Pioneering, Inc., its manager, By: /s/ Noubar B. Afeyan, PhD., Chief Executive Officer
All Insider Reports
All Insider Reports

Ownership of Flagship Pioneering Fund VII General Partner LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OMGAQ Omega Therapeutics, Inc. 10%+ Owner $10.6M Feb 27, 2023
MCRB Seres Therapeutics, Inc. 10%+ Owner $7.86M Jul 5, 2022
EVLO Evelo Biosciences, Inc. 10%+ Owner $4.52M May 27, 2022
FHTX Foghorn Therapeutics Inc. 10%+ Owner May 22, 2024
SANA Sana Biotechnology, Inc. 10%+ Owner Feb 12, 2024

There are no insider transactions reported by Flagship Pioneering Fund VII General Partner LLC